Next Generation Sequencing in the Clinic: a Patterns of Care Study in a Retrospective Cohort of Subjects Referred to a Genetic Medicine Clinic for Suspected Lynch Syndrome
- 5 December 2015
- journal article
- Published by Wiley in Journal of Genetic Counseling
- Vol. 25 (3) , 515-519
Abstract
Next generation sequencing (NGS) gene panels are increasingly used in medical genetics clinics for the evaluation of common inherited cancer syndromes, but the clinical efficacy of these tests, and the factors driving clinical providers to order them are unclear. We conducted a patterns‐of‐care study to compare patients evaluated with NGS gene panels with a reference group. We abstracted demographic, socioeconomic, and clinical information in a retrospective cohort of patients referred to a large medical genetics clinic for evaluation of inherited colorectal cancer and polyposis syndromes. Patients tested with NGS gene panels were more likely to be insured compared to the reference group (85.3 % vs. 69.2 %, p = 0.0068),less likely to have prior tumor tissue testing (29.4 % vs. 54.3 %, p = 0.0004), and less likely to have an abnormal tumor tissue test result (46.7 % vs. 74.5 %, p = 0.01). No significant differences were found between groups in age, gender, race, employment status, personal history of colorectal cancer, or proportion of patients fulfilling Lynch syndrome clinical criteria. Patients with NGS testing were less likely to have a pathogenic/likely pathogenic variant detected (13.7 % vs. 31.9 %, p = 0.002). Patients referred for NGS testing to evaluate inherited colorectal cancer/polyposis risk appear to undergo tumor tissue testing less frequently than non‐NGS testing patients. Further studies are needed to assess the most effective and cost‐effective approach to genomic diagnosis in this patient population.Keywords
This publication has 10 references indexed in Scilit:
- Next-Generation Sequencing Panels for the Diagnosis of Colorectal Cancer and Polyposis Syndromes: A Cost-Effectiveness AnalysisJournal of Clinical Oncology, 2015
- Comparative effectiveness of next generation genomic sequencing for disease diagnosis: Design of a randomized controlled trial in patients with colorectal cancer/polyposis syndromesContemporary Clinical Trials, 2014
- Collaboration of Colorado Cancer Genetic Counselors to Integrate Next Generation Sequencing Panels into Clinical PracticeJournal of Genetic Counseling, 2014
- The Evolution of Cancer Risk Assessment in the Era of Next Generation SequencingJournal of Genetic Counseling, 2014
- Panel‐based testing for inherited colorectal cancer: a descriptive study of clinical testing performed by a US laboratoryClinical Genetics, 2014
- Impact of NGS in the medical sciences: genetic syndromes with an increased risk of developing cancer as an example of the use of new technologiesGenetics and Molecular Biology, 2014
- ColoSeq Provides Comprehensive Lynch and Polyposis Syndrome Mutational Analysis Using Massively Parallel SequencingThe Journal of Molecular Diagnostics, 2012
- Human Genome Sequencing in Health and DiseaseAnnual Review of Medicine, 2012
- Deletions removing the last exon ofTACSTD1constitute a distinct class of mutations predisposing to Lynch syndromeHuman Mutation, 2009
- Revised Bethesda Guidelines for Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) and Microsatellite InstabilityJNCI: Journal of the National Cancer Institute, 2004